|

ART0380 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Artios Pharma Ltd1

Indications

  • Acinar Cell Carcinoma1
  • Fallopian Tube Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Primary Peritoneal Cancer1
  • Advanced Cancer1

Birmingham, Alabama1 trial

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

University of Alabama at Birmingham

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.